Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aurobindo Pharma Limited

https://www.aurobindo.com/

Latest From Aurobindo Pharma Limited

Aurobindo Eyes Opportunities After Offloading Natrol For $550m

Aurobindo has agreed to sell its US-based Natrol dietary supplements business at a significant premium to the $132.5m it paid in late 2014, as the Indian firm continues to drive into complex formulations in the US, including injectables and biosimilars.

Deals Dietary Supplements

Coronavirus Update: Moderna In Advanced Talks With Europe On Vaccine Supplies

The deal would include an option for expansion to 160 million doses of the mRNA-based vaccine.

Coronavirus COVID-19 Vaccines

Aurobindo's US Respiratory Filing Could Rival Teva's Qvar

Amid speculation it has filed for a generic to Teva’s asthma product Qvar in the US, Aurobindo hopes a healthy product pipeline will help it maintain growth despite pandemic-led challenges. Meanwhile, building on assets acquired from Profectus BioSciences, the firm has thrown its hat in the ring for a COVID-19 vaccine.

Sales & Earnings Strategy

Aurobindo Enters Fray For COVID-19 Vaccine

Building on assets acquired from Profectus BioSciences, Aurobindo Pharma has thrown its hat in the ring for a COVID-19 vaccine. Amid speculation it has filed for a generic to Teva’s asthma product Qvar in the US, the company hopes a healthy product pipeline will help it maintain growth despite pandemic-led challenges.

Commercial Sales & Earnings
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
  • Other Names / Subsidiaries
    • Acrotech Biopharma, LLC
    • APL
    • Glaxo (India)
    • TL Biopharmaceutical AG.
UsernamePublicRestriction

Register